The t(9;22) chromosome translocation originating from the BCR-ABL1 fusion oncoprotein is detected most commonly in chronic myeloid leukemia (CML), occurring in approximately 95% of the cases and representing the hallmark of this disease. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.